Design and created by Guideline Central in participation with the American Society of Addiction Medicine.
The Joint Clinical Practice Guideline on Benzodiazepine Tapering. Available at: https://www.asam.org/quality-care/clinical-guidelines/benzodiazepine-tapering.
This clinical practice guideline has been endorsed by the American Academy of Neurology, the American Academy of Physician Associates, the American Association of Nurse Practitioners, the American Association of Psychiatric Pharmacists, the American College of Medical Toxicology, the American College of Obstetricians and Gynecology, the American Geriatrics Society, and the American Society of Addiction Medicine.
D001569 - Benzodiazepines
D000084862 - Drug Tapering
D001569 - Benzodiazepines
D000084862 - Drug Tapering
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.